Fresenius Medical Care AG & Co. KGaA
FMSNYSEHealthcare● Active
$21.79
$-0.24(-1.09%)
Market Cap$11.7B
P/E Ratio—
52W High$29.07
52W Low$20.02
Fresenius Medical Care AG & Co. KGaA (FMS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
FMS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$0.53
Est. $0.59 · -10.2%
Revenue
$5.40B
Est. $5.41B · -0.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▼ Miss EPS
FMS reports quarterly as a NYSE-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.49B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.49B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $0.62 | — | — | — | $5.55B | — |
| ▼ Q2 FY2026 | May 5, 2026 | $0.59 | $0.53 | -10.2% | $5.40B | $5.41B | -0.1% |
| ▲ Q1 FY2026 | Feb 24, 2026 | $0.65 | $0.83 | +28.3% | $5.97B | $5.67B | +5.3% |
| ▲ Q4 FY2025 | Nov 4, 2025 | $0.59 | $0.64 | +8.5% | $5.72B | $4.80B | +19.2% |
| ▲ Q3 FY2025 | Aug 5, 2025 | $0.50 | $0.52 | +4.0% | $5.64B | $4.98B | +13.4% |
| ▲ Q2 FY2025 | May 6, 2025 | $0.43 | $0.44 | +2.3% | $5.35B | $5.06B | +5.8% |
| ▲ Q1 FY2025 | Feb 25, 2025 | $0.41 | $0.48 | +17.1% | $5.27B | $4.66B | +13.1% |
| ▲ Q4 FY2024 | Nov 5, 2024 | $0.38 | $0.45 | +18.4% | $5.22B | $5.22B | -0.1% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$0.62
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Miss
EPS Actual
$0.53
EPS Est.
$0.59
EPS Surpr.
-10.2%
Revenue
$5.40B
Q1 FY2026
Feb 24, 2026Beat
EPS Actual
$0.83
EPS Est.
$0.65
EPS Surpr.
+28.3%
Revenue
$5.97B
Q4 FY2025
Nov 4, 2025Beat
EPS Actual
$0.64
EPS Est.
$0.59
EPS Surpr.
+8.5%
Revenue
$5.72B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
$0.52
EPS Est.
$0.50
EPS Surpr.
+4.0%
Revenue
$5.64B
Q2 FY2025
May 6, 2025Beat
EPS Actual
$0.44
EPS Est.
$0.43
EPS Surpr.
+2.3%
Revenue
$5.35B
Q1 FY2025
Feb 25, 2025Beat
EPS Actual
$0.48
EPS Est.
$0.41
EPS Surpr.
+17.1%
Revenue
$5.27B
Q4 FY2024
Nov 5, 2024Beat
EPS Actual
$0.45
EPS Est.
$0.38
EPS Surpr.
+18.4%
Revenue
$5.22B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2026 | $0.57 | $0.58 | $0.59 | 1 |
| Q3 FY2026 | $0.54 | $0.57 | $0.60 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $4.1B | $4.1B | $4.2B | 1 |
| Q3 FY2027 | $6.1B | $6.2B | $6.2B | 2 |
| Q2 FY2027 | $6.1B | $6.2B | $6.2B | 2 |
| Q1 FY2027 | $4.1B | $4.1B | $4.2B | 1 |
| Q4 FY2026 | $5.1B | $5.1B | $5.2B | 2 |
| Q3 FY2026 | $4.9B | $5.0B | $5.0B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 5, 2026 | -10.2% | $22.65 | $20.19 | -10.86% |
| ▲ Q1 FY2026 | Feb 24, 2026 | +28.3% | $24.59 | $22.66 | -7.85% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +8.5% | $26.35 | $24.29 | -7.82% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +4.0% | $24.94 | $24.42 | -2.09% |
| ▲ Q2 FY2025 | May 6, 2025 | +2.3% | $25.62 | $27.41 | +6.99% |
| ▲ Q1 FY2025 | Feb 25, 2025 | +17.1% | $23.31 | $23.45 | +0.60% |
| ▲ Q4 FY2024 | Nov 5, 2024 | +18.4% | $20.05 | $20.33 | +1.40% |
| ▲ Q3 FY2024 | Jul 30, 2024 | +0.0% | $20.36 | $19.63 | -3.59% |
Q2 FY2026-10.86%
Report Date
May 5, 2026
EPS Beat/Miss
-10.2%
Price Before
$22.65
Price After
$20.19
Q1 FY2026-7.85%
Report Date
Feb 24, 2026
EPS Beat/Miss
+28.3%
Price Before
$24.59
Price After
$22.66
Q4 FY2025-7.82%
Report Date
Nov 4, 2025
EPS Beat/Miss
+8.5%
Price Before
$26.35
Price After
$24.29
Q3 FY2025-2.09%
Report Date
Aug 5, 2025
EPS Beat/Miss
+4.0%
Price Before
$24.94
Price After
$24.42
Q2 FY2025+6.99%
Report Date
May 6, 2025
EPS Beat/Miss
+2.3%
Price Before
$25.62
Price After
$27.41
Q1 FY2025+0.60%
Report Date
Feb 25, 2025
EPS Beat/Miss
+17.1%
Price Before
$23.31
Price After
$23.45
Q4 FY2024+1.40%
Report Date
Nov 5, 2024
EPS Beat/Miss
+18.4%
Price Before
$20.05
Price After
$20.33
Q3 FY2024-3.59%
Report Date
Jul 30, 2024
EPS Beat/Miss
+0.0%
Price Before
$20.36
Price After
$19.63
Avg Beat Reaction-1.77%
Avg Miss Reaction-10.86%
Beat Rate7 / 8 quarters
Largest Move-10.86% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: FMS ends December
Fresenius Medical Care AG & Co. KGaA (FMS) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $0.53 — missing the analyst consensus of $0.59 by -10.2%. The next FMS earnings date is expected around September 1, 2026.
Each quarter, investors track FMS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. FMS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
FMS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
FMS earnings · 5 questionsFresenius Medical Care AG & Co. KGaA's next earnings report is expected around September 1, 2026. FMS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; FMS historically reports after market close (AMC).
FMS earnings datewhen is FMS earningsFMS next earnings datewhen does FMS report earningsFMS earnings calendar
▸ Source: FMP · Fresenius Medical Care AG & Co. KGaA SEC filings · US GAAP · Fresenius Medical Care AG & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026